Home  >  News
  Inovio, Partners begin phase 1/2a trial to advance its vaccine against deadly MERS infection,   September 20, 2017
  Pharnext amends protocol of international pivotal phase 3 trials of PXT3003 for Charcot-Marie-Tooth disease type 1A,   September 20, 2017
  EMA committee issues positive opinion for an update of SmPC for Pradaxa,   September 20, 2017
  Thrombolytic Science completes phase 1 trial of novel clot-dissolving therapy, TS01,   September 20, 2017
  AbbVie reports positive results from phase 3 trial of Venclexta/Venclyxto in combo with Rituxan to treat patients with relapsed/refractory CLL,   September 20, 2017
  Sanofi, Regeneron announce positive results from phase 3 CAFÉ study of Dupixent in p With moderate-to-severe AD,   September 19, 2017
  Novartis' Xolair confirms re-treatment efficacy in chronic spontaneous urticaria patients after treatment interruption,   September 18, 2017
  Novo Nordisk's Devote trial shows that people with type 2 diabetes can hypoglycaemia complication,   September 18, 2017
  Biohaven, ADCS partner to evaluate trigriluzole in patients with Alzheimer's disease,   September 18, 2017
  Amgen announces new FOURIER study shows Repatha reduces CV events in patients with diabetes,   September 18, 2017
  Vanda Pharma announces positive data from phase II study of tradipitant to treat patients with atopic dermatitis,   September 16, 2017
  AstraZeneca announces EXSCEL trial shows CV safety with Bydureon in patients with T2D at wide range of CV risk,   September 16, 2017
  Aster Prime Hospital enrolls patients for CANTOS international study to reduce risk of heart diseases,   September 16, 2017
  Oncolytics Biotech begins phase 1b trial MUK eleven of Reolysin in combo with Revlimid/Imnovid in relapsing myeloma patients,   September 15, 2017
  Researchers turn to creative approaches to battle kidney stones,   September 15, 2017
  Pfizer, Astellas announce positive results from phase 3 PROSPER trial of Xtandi in Patients with non-metastatic CRPC,   September 15, 2017
  Roche presents positive six month study data from Esbriet in combo with nintedanib in patients with IPF at ERS congress,   September 14, 2017
  Novartis' Cosentyx sets new benchmark in psoriasis with robust 5-year sustained phase III efficacy & safety data,   September 14, 2017
  Study shows Jardiance tablets reduce risk of CV death in people with type 2 diabetes & established CV disease, independent of blood sugar control,   September 13, 2017
  Inovio’s cancer immunotherapy slowed PSA rise & significantly increased PSA doubling times in recurrent prostate cancer patients,   September 13, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |